Prognostic value of contrast-enhanced cardiac magnetic resonance imaging in patients with newly diagnosed non-ischemic cardiomyopathy: cohort study.
about
Cardiac Magnetic Resonance Scar Imaging for Sudden Cardiac Death Risk Stratification in Patients with Non-Ischemic CardiomyopathyLate Gadolinium Enhancement in Patients with Nonischemic Dilated Cardiomyopathy.Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis.Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction.Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early risk-stratification of nonischemic cardiomyopathy: a cohort study.Endogenous assessment of chronic myocardial infarction with T(1ρ)-mapping in patientsComparison of Ventricular Inducibility with Late Gadolinium Enhancement and Myocardial Inflammation in Endomyocardial Biopsy in Patients with Dilated CardiomyopathyLate gadolinium enhancement on cardiac magnetic resonance predicts coronary vasomotor abnormality and myocardial lactate production in patients with chronic heart failure.Endogenous contrast MRI of cardiac fibrosis: beyond late gadolinium enhancement.Diagnostic and prognostic roles of echocardiography and cardiac magnetic resonanceDistribution of ventricular fibrosis associated with life threatening ventricular tachyarrhythmias in patients with nonishcemic dilated cardiomyopathy.Crown years for non-invasive cardiovascular imaging (Part III): 30 years cardiovascular magnetic resonance.Late gadolinium enhancement on cardiac magnetic resonance imaging is associated with coronary endothelial dysfunction in patients with dilated cardiomyopathy.Myocardial expression of the anaphylatoxin receptor C3aR is associated with cardiac inflammation and prognosis in patients with non-ischaemic heart failure
P2860
Q26801712-86AB4363-93CD-4434-8D74-ACE78655E108Q30251600-A94AFD7A-2D58-4598-A3BA-BACBECEAD5BAQ30407667-01AC0D67-1791-4411-891C-C50060FE3282Q33727302-FD5F8300-5070-4C5C-8B56-210F33CDB6AAQ34130016-4E6477C7-85E7-431E-8A23-37F09D6E1BCDQ34746688-3319DEF0-B43E-4A95-AD1A-4979208FC835Q36216050-917F45AD-19D3-4512-99B5-C638AD53A16AQ37438268-8DB291A1-146C-4CBF-8C36-4822C9D00A7FQ38236811-19DC8352-7FE5-49F8-A68C-63981E6A917BQ38912706-D6D282BB-0D28-4165-A53E-0C36D37D3154Q38979737-C700F44E-9514-4B00-8753-BE2FBC128041Q40953855-A08828A5-F9CA-45C9-B17D-9609368C3763Q50100084-A861B328-CB71-4F58-8D0D-918CEA09E4BEQ58778850-5E21B291-D12C-4443-BD6A-95DDDD26CA4D
P2860
Prognostic value of contrast-enhanced cardiac magnetic resonance imaging in patients with newly diagnosed non-ischemic cardiomyopathy: cohort study.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Prognostic value of contrast-e ...... cardiomyopathy: cohort study.
@ast
Prognostic value of contrast-e ...... cardiomyopathy: cohort study.
@en
Prognostic value of contrast-e ...... cardiomyopathy: cohort study.
@nl
type
label
Prognostic value of contrast-e ...... cardiomyopathy: cohort study.
@ast
Prognostic value of contrast-e ...... cardiomyopathy: cohort study.
@en
Prognostic value of contrast-e ...... cardiomyopathy: cohort study.
@nl
prefLabel
Prognostic value of contrast-e ...... cardiomyopathy: cohort study.
@ast
Prognostic value of contrast-e ...... cardiomyopathy: cohort study.
@en
Prognostic value of contrast-e ...... cardiomyopathy: cohort study.
@nl
P2093
P2860
P1433
P1476
Prognostic value of contrast-e ...... cardiomyopathy: cohort study.
@en
P2093
Axel Bauer
Christine S Zuern
Iris Müller
Karin A L Müller
Meinrad Gawaz
Ulrich Kramer
P2860
P304
P356
10.1371/JOURNAL.PONE.0057077
P407
P577
2013-02-20T00:00:00Z